Intra-Cellular Therapies
ITCI
#1832
Rank
HK$69.74 B
Marketcap
HK$657.87
Share price
-1.30%
Change (1 day)
44.17%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -HK$12.61

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -HK$12.53. In 2022 the company made an earnings per share (EPS) of -HK$21.17 an increase over its 2021 EPS that were of -HK$27.24.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$12.61-40.42%
2022-HK$21.17-22.29%
2021-HK$27.248.02%
2020-HK$25.2220.9%
2019-HK$20.86-5.63%
2018-HK$22.1033.96%
2017-HK$16.50-21.19%
2016-HK$20.94-7.56%
2015-HK$22.65174.53%
2014-HK$8.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$1.95-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$77.83 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$16.65 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA